M R Teixeira M, B Assunção C, R Gomes R, Rocha-Silva F, M de Figueiredo S, R R Teixeira E, et al. A case of subcutaneous phaeohyphomycosis associated with leprosy. Infectious disorders drug targets. 2017;

Pouldar D, Teles R, Modlin R. PLAU and SerpinB2 role in apoptosis in leprosy. Journal of the American Academy of Dermatology. 2017;76(6):AB199.

Ghunawat S, Relhan V, Garg V. A 10-year retrospective analysis of leprosy cases in a hospital setup in India: Scenario in post MDT era. Journal of the American Academy of Dermatology. 2017;76(6):AB2.

Keed A. Leprosy: a forgotten disease? Medicine today. 2017;18(5):61-6.

Long S. Barriers to prevent disability due to leprosy in children are breachable. The Journal of pediatrics [Internet]. 2017;185:3. Available from: http://www.jpeds.com/article/S0022-3476(17)30499-7/pdf

Bichara CNC, Bichara CDA, Tostes C, Povoa MM, Quaresma JAS, Xavier MB. Prevalence of autoantibodies against cellular antigens in patients with HIV and leprosy coinfection in the Amazon region. Infectious diseases of poverty [Internet]. 2017;6(1):80. Available from: http://tinyurl.com/yavhtrkp

Araujo S, Goulart LR, Truman RW, Goulart IM, Vissa V, Li W, et al. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. PLoS neglected tropical diseases [Internet]. 2017;11(6):e0005506. Available from: http://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0005506&type=printable

Sykam A, Gutlapalli, Tenali S, Meena, Chandran P, Suneetha S, et al. Anticeramide antibody and butyrylcholinesterase in peripheral neuropathies. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2017;

WADE. The first phase of borderline transformation. The so-called "relapsed tuberculoid" condition. International journal of Leprosy [Internet]. 1960;28:105-12. Available from: http://ila.ilsl.br/pdfs/v28n2a01.pdf

Mendes MA, Carvalho DS, Amadeu TP, Andrade Silva BJ, Prata RBS, Silva CO, et al. Elevated Pentraxin-3 concentrations in leprosy patients: potential biomarker of Erythema Nodosum Leprosum. The Journal of infectious diseases. 2017;